Cellular pharmacology of the combination of the DNA topoisomerase I inhibitor SN-38 and the diaminocyclohexane platinum derivative oxaliplatin.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples